Cite
HARVARD Citation
Hatayama, S. et al. (2022). Two cases with fulminant type 1 diabetes that developed long after cessation of immune checkpoint inhibitor treatment. Journal of diabetes investigation. 13 (8), pp. 1458-1460. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hatayama, S. et al. (2022). Two cases with fulminant type 1 diabetes that developed long after cessation of immune checkpoint inhibitor treatment. Journal of diabetes investigation. 13 (8), pp. 1458-1460. [Online].